GO:0034660 | ncRNA metabolic process | 10.2% (5/49) | 4.07 | 1.2e-05 | 0.001548 |
GO:0006399 | tRNA metabolic process | 8.16% (4/49) | 4.45 | 3.4e-05 | 0.002202 |
GO:0004386 | helicase activity | 8.16% (4/49) | 4.53 | 2.8e-05 | 0.002405 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 14.29% (7/49) | 3.19 | 1.1e-05 | 0.002806 |
GO:0140098 | catalytic activity, acting on RNA | 10.2% (5/49) | 3.4 | 0.000111 | 0.005691 |
GO:0016070 | RNA metabolic process | 14.29% (7/49) | 2.62 | 0.000133 | 0.005704 |
GO:1901363 | heterocyclic compound binding | 26.53% (13/49) | 1.51 | 0.000415 | 0.006272 |
GO:0032553 | ribonucleotide binding | 24.49% (12/49) | 1.58 | 0.000464 | 0.006275 |
GO:0006325 | chromatin organization | 6.12% (3/49) | 4.81 | 0.000172 | 0.006322 |
GO:0032559 | adenyl ribonucleotide binding | 24.49% (12/49) | 1.71 | 0.000198 | 0.006348 |
GO:0036094 | small molecule binding | 26.53% (13/49) | 1.5 | 0.000449 | 0.006414 |
GO:0030014 | CCR4-NOT complex | 4.08% (2/49) | 6.12 | 0.000376 | 0.006442 |
GO:0140101 | catalytic activity, acting on a tRNA | 6.12% (3/49) | 4.45 | 0.000358 | 0.006578 |
GO:0097367 | carbohydrate derivative binding | 24.49% (12/49) | 1.56 | 0.000514 | 0.006599 |
GO:0032555 | purine ribonucleotide binding | 24.49% (12/49) | 1.6 | 0.000414 | 0.006651 |
GO:0035639 | purine ribonucleoside triphosphate binding | 22.45% (11/49) | 1.65 | 0.000549 | 0.006719 |
GO:0071824 | protein-DNA complex organization | 6.12% (3/49) | 4.46 | 0.000347 | 0.006858 |
GO:0005524 | ATP binding | 22.45% (11/49) | 1.79 | 0.000251 | 0.007179 |
GO:0043933 | protein-containing complex organization | 8.16% (4/49) | 3.59 | 0.000343 | 0.007354 |
GO:0030554 | adenyl nucleotide binding | 24.49% (12/49) | 1.64 | 0.00032 | 0.007471 |
GO:0017076 | purine nucleotide binding | 24.49% (12/49) | 1.53 | 0.000649 | 0.007586 |
GO:0140657 | ATP-dependent activity | 10.2% (5/49) | 2.81 | 0.000712 | 0.007955 |
GO:0043168 | anion binding | 26.53% (13/49) | 1.55 | 0.000312 | 0.008024 |
GO:0090304 | nucleic acid metabolic process | 14.29% (7/49) | 2.15 | 0.00091 | 0.009745 |
GO:1901265 | nucleoside phosphate binding | 24.49% (12/49) | 1.45 | 0.001051 | 0.01039 |
GO:0000166 | nucleotide binding | 24.49% (12/49) | 1.45 | 0.001051 | 0.01039 |
GO:0034470 | ncRNA processing | 6.12% (3/49) | 3.85 | 0.001203 | 0.011448 |
GO:0101030 | tRNA-guanine transglycosylation | 2.04% (1/49) | 9.37 | 0.001511 | 0.013865 |
GO:0006400 | tRNA modification | 4.08% (2/49) | 4.98 | 0.001852 | 0.014871 |
GO:0009987 | cellular process | 38.78% (19/49) | 0.96 | 0.001806 | 0.014974 |
GO:0016874 | ligase activity | 6.12% (3/49) | 3.67 | 0.001709 | 0.015145 |
GO:0016043 | cellular component organization | 10.2% (5/49) | 2.51 | 0.00179 | 0.015337 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.08% (2/49) | 4.59 | 0.003154 | 0.016542 |
GO:0043039 | tRNA aminoacylation | 4.08% (2/49) | 4.59 | 0.003154 | 0.016542 |
GO:0043038 | amino acid activation | 4.08% (2/49) | 4.59 | 0.003154 | 0.016542 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4.08% (2/49) | 4.59 | 0.003154 | 0.016542 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 4.08% (2/49) | 4.59 | 0.003154 | 0.016542 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.29% (7/49) | 1.83 | 0.003275 | 0.016832 |
GO:0006396 | RNA processing | 8.16% (4/49) | 2.86 | 0.002219 | 0.017283 |
GO:0003989 | acetyl-CoA carboxylase activity | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0008479 | tRNA-guanosine(34) queuine transglycosylase activity | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0016885 | ligase activity, forming carbon-carbon bonds | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0006433 | prolyl-tRNA aminoacylation | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0000829 | inositol heptakisphosphate kinase activity | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0034457 | Mpp10 complex | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0004827 | proline-tRNA ligase activity | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0016421 | CoA carboxylase activity | 2.04% (1/49) | 8.37 | 0.003019 | 0.017633 |
GO:0008186 | ATP-dependent activity, acting on RNA | 4.08% (2/49) | 4.67 | 0.002824 | 0.020739 |
GO:0003724 | RNA helicase activity | 4.08% (2/49) | 4.67 | 0.002824 | 0.020739 |
GO:0004828 | serine-tRNA ligase activity | 2.04% (1/49) | 7.79 | 0.004525 | 0.021143 |
GO:0030041 | actin filament polymerization | 2.04% (1/49) | 7.79 | 0.004525 | 0.021143 |
GO:0006434 | seryl-tRNA aminoacylation | 2.04% (1/49) | 7.79 | 0.004525 | 0.021143 |
GO:0071840 | cellular component organization or biogenesis | 10.2% (5/49) | 2.34 | 0.002989 | 0.021339 |
GO:0006338 | chromatin remodeling | 4.08% (2/49) | 4.35 | 0.004375 | 0.022049 |
GO:0008033 | tRNA processing | 4.08% (2/49) | 4.33 | 0.004508 | 0.022279 |
GO:0046483 | heterocycle metabolic process | 14.29% (7/49) | 1.69 | 0.005539 | 0.025422 |
GO:0072546 | EMC complex | 2.04% (1/49) | 7.37 | 0.006029 | 0.026261 |
GO:0051258 | protein polymerization | 2.04% (1/49) | 7.37 | 0.006029 | 0.026261 |
GO:0006725 | cellular aromatic compound metabolic process | 14.29% (7/49) | 1.66 | 0.006211 | 0.026603 |
GO:0043167 | ion binding | 28.57% (14/49) | 1.03 | 0.005936 | 0.026766 |
GO:1901360 | organic cyclic compound metabolic process | 14.29% (7/49) | 1.63 | 0.006893 | 0.029039 |
GO:0032991 | protein-containing complex | 12.24% (6/49) | 1.8 | 0.007192 | 0.02981 |
GO:0005488 | binding | 48.98% (24/49) | 0.64 | 0.007812 | 0.03187 |
GO:0008318 | protein prenyltransferase activity | 2.04% (1/49) | 6.79 | 0.00903 | 0.035161 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 2.04% (1/49) | 6.79 | 0.00903 | 0.035161 |
GO:0005885 | Arp2/3 protein complex | 2.04% (1/49) | 6.79 | 0.00903 | 0.035161 |
GO:0018342 | protein prenylation | 2.04% (1/49) | 6.56 | 0.010527 | 0.039785 |
GO:0097354 | prenylation | 2.04% (1/49) | 6.56 | 0.010527 | 0.039785 |
GO:0110053 | regulation of actin filament organization | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0030833 | regulation of actin filament polymerization | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0030544 | Hsp70 protein binding | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0008064 | regulation of actin polymerization or depolymerization | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0002098 | tRNA wobble uridine modification | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0032956 | regulation of actin cytoskeleton organization | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0032970 | regulation of actin filament-based process | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0030832 | regulation of actin filament length | 2.04% (1/49) | 6.2 | 0.013515 | 0.0457 |
GO:0043254 | regulation of protein-containing complex assembly | 2.04% (1/49) | 6.05 | 0.015005 | 0.048204 |
GO:0032271 | regulation of protein polymerization | 2.04% (1/49) | 6.05 | 0.015005 | 0.048204 |
GO:0002097 | tRNA wobble base modification | 2.04% (1/49) | 6.05 | 0.015005 | 0.048204 |
GO:1902903 | regulation of supramolecular fiber organization | 2.04% (1/49) | 6.05 | 0.015005 | 0.048204 |
GO:0032535 | regulation of cellular component size | 2.04% (1/49) | 5.91 | 0.016493 | 0.049868 |
GO:0090066 | regulation of anatomical structure size | 2.04% (1/49) | 5.91 | 0.016493 | 0.049868 |
GO:0031011 | Ino80 complex | 2.04% (1/49) | 5.91 | 0.016493 | 0.049868 |
GO:0097346 | INO80-type complex | 2.04% (1/49) | 5.91 | 0.016493 | 0.049868 |